TipRanks
Advertisement
Advertisement

DE:PX91 Stock Latest News

Filana can proceed with study as hold lifted, says Lucid Capital
The FlyFilana can proceed with study as hold lifted, says Lucid Capital
16d ago
FLNA
Filana Therapeutics advances simufilam in TSC epilepsy trial
PremiumCompany Announcements
Filana Therapeutics advances simufilam in TSC epilepsy trial
16d ago
8K
FLNA
Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam
PremiumThe Fly
Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam
16d ago
FLNA
Filana Therapeutics Receives Nasdaq Minimum Bid Price Notice
PremiumCompany Announcements
Filana Therapeutics Receives Nasdaq Minimum Bid Price Notice
20d ago
8K
FLNA
FLNA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
FLNA Earnings this Week: How Will it Perform?
2M ago
FLNA
Jason McCarthy Reiterates Buy on Filana, Maintains Unchanged $5 Price Target Amid Advancing Simufilam TSC Epilepsy Strategy
PremiumRatingsJason McCarthy Reiterates Buy on Filana, Maintains Unchanged $5 Price Target Amid Advancing Simufilam TSC Epilepsy Strategy
2M ago
FLNA
Filana Therapeutics Shareholders Back Board, Compensation Plans
Premium
Company Announcements
Filana Therapeutics Shareholders Back Board, Compensation Plans
4M ago
8K
FLNA
Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot
Premium
The Fly
Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot
5M ago
FLNA
Filana Therapeutics resumed with a Buy at Maxim
PremiumThe Fly
Filana Therapeutics resumed with a Buy at Maxim
5M ago
FLNA
Filana Therapeutics publishes simufilam preclinical data
PremiumThe Fly
Filana Therapeutics publishes simufilam preclinical data
6M ago
FLNA
Filana Therapeutics management to meet with Maxim
PremiumThe Fly
Filana Therapeutics management to meet with Maxim
7M ago
FLNA
Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year
PremiumThe Fly
Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year
7M ago
FLNA
Filana Therapeutics sees 1H26 net cash use in operations $14M-$17M
PremiumThe FlyFilana Therapeutics sees 1H26 net cash use in operations $14M-$17M
7M ago
FLNA
Two new option listings and one option delisting on March 11th
Premium
The Fly
Two new option listings and one option delisting on March 11th
7M ago
SAVA
Two new option listings and one option delisting on March 11th
Premium
The Fly
Two new option listings and one option delisting on March 11th
7M ago
SAVA
Cassava Sciences Rebrands as Filana Therapeutics, Updates Ticker
PremiumCompany Announcements
Cassava Sciences Rebrands as Filana Therapeutics, Updates Ticker
7M ago
8K
SAVA
Cassava Sciences announces name change to Filana Therapeutics
PremiumThe Fly
Cassava Sciences announces name change to Filana Therapeutics
7M ago
SAVA
Is SAVA a Buy, Before Earnings?
PremiumPre-Earnings
Is SAVA a Buy, Before Earnings?
7M ago
SAVA
Trump Trade: Warner sale triggers probe on theater, film release impact
PremiumThe Fly
Trump Trade: Warner sale triggers probe on theater, film release impact
8M ago
JPM
LYV
Cassava Sciences DOJ Inquiry Closed, Legal Overhang Eased
PremiumCompany AnnouncementsCassava Sciences DOJ Inquiry Closed, Legal Overhang Eased
8M ago
8K
SAVA
Cassava Sciences announces closure of DOJ investigation
Premium
The Fly
Cassava Sciences announces closure of DOJ investigation
8M ago
SAVA
Cassava Sciences announces publication of Phase 3 results for simufilam
Premium
The Fly
Cassava Sciences announces publication of Phase 3 results for simufilam
9M ago
SAVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >